Case report: Dupilumab leads to an increased chance of head and neck <i>Staphylococcus aureus</i> infection in atopic dermatitis patients.

Case report: Dupilumab leads to an increased chance of head and neck Staphylococcus aureus infection in atopic dermatitis patients.

Chen, Min; Gao, Kai; Ali, Kamran; Shan, Jinpeng; Qiu, YunMi; Xie, Tianci; Yu, Yiling; Wu, Liming.

Afiliação

Chen M; Department of Dermatology, The Fourth School of Medicine Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Gao K; Department of Dermatology, The Fourth School of Medicine Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Ali K; Department of Dermatology, The Fourth School of Medicine Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Shan J; Department of Dermatology, The Fourth School of Medicine Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Qiu Y; Department of Dermatology, The Fourth School of Medicine Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Xie T; Department of Dermatology, The Fourth School of Medicine Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Yu Y; Department of Dermatology, The Fourth School of Medicine Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Wu L; Department of Dermatology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Front Med (Lausanne) ; 10: 1027589, 2023.

Article em En | MEDLINE | ID: mdl-36968828

ABSTRACT

Dupilumab was the first biological medication licensed to treat atopic dermatitis (AD), and it has shown remarkable effectiveness and safety in the treatment of moderate-to-severe atopic dermatitis. There are limited drug-related adverse events associated with dupilumab in atopic dermatitis (AD) treatment. Here, we present two cases of local Staphylococcus aureus infection during the treatment of atopic dermatitis with dupilumab.

Palavras-chave

Staphylococcus aureus infection; adverse event; atopic dermatitis; drug reaction; dupilumab adverse reactions

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article